🇺🇸 ACTH in United States

FDA authorised ACTH on 29 April 1952

Marketing authorisations

FDA — authorised 29 April 1952

  • Application: NDA008372
  • Marketing authorisation holder: MALLINCKRODT IRELAND
  • Local brand name: ACTHAR GEL (AUTOINJECTOR)
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 16 June 1954

  • Application: NDA008975
  • Marketing authorisation holder: ANI PHARMS
  • Local brand name: PURIFIED CORTROPHIN GEL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA — authorised 12 September 1957

  • Application: NDA010831
  • Marketing authorisation holder: ORGANICS LAGRANGE
  • Local brand name: CORTICOTROPIN
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Application: ANDA088772
  • Marketing authorisation holder: WATSON LABS
  • Local brand name: CORTICOTROPIN
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

Frequently asked questions

Is ACTH approved in United States?

Yes. FDA authorised it on 29 April 1952; FDA authorised it on 16 June 1954; FDA authorised it on 12 September 1957.

Who is the marketing authorisation holder for ACTH in United States?

MALLINCKRODT IRELAND holds the US marketing authorisation.